{'fraction_non_alphanumeric': 0.027938342967244702, 'fraction_numerical': 0.015414258188824663, 'mean_word_length': 5.453416149068323, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Modern Principles of Adjuvant Therapy of COVID-19

COVID-19 pandemic brings new challenges to healthcare systems all around the world. According to the literature, 80 % of patients have a mild or moderate disease, that doesn’t require inpatient care. Primary health-care providers play a great role in management such patients. There are no recommendations for the outpatient management for mild or moderate cases of COVID-19, including effective monitoring and prevention of severe cases . The article presents recent data of laboratory and clinical studies of prevention agents, outpatient treatment regimens approved by the EVMS Critical Care COVID-19 Management Protocol dated September 28, 2020.Recommendations include dynamic monitoring of the patient at home (including pulseoximetry), using regimens such as melatonin, vitamin C, vitamin D, zinc, magnesium and others. Except general restorative effect, these regimens prevent the severe disease, and play a certain role in dampening the cytokine storm, facilitate early recovery.